Skip to main content
Cell Journal (Yakhteh) logoLink to Cell Journal (Yakhteh)
. 2018 May 28;20(3):449. doi: 10.22074/cellj.2018.6018

COMPARE CPM-RMI Trial: Intramyocardial Transplantation of Autologous Bone Marrow-Derived CD133+ Cells and MNCs during CABG in Patients with Recent MI: A Phase II/III, Multicenter, Placebo-Controlled, Randomized, Double-Blind Clinical Trial

Mohammad Hassan Naseri 1,#, Hoda Madani 2,#, Seyed Hossein Ahmadi Tafti 3, Maryam Moshkani Farahani 4, Davood Kazemi Saleh 5, Hossein Hosseinnejad 6, Saeid Hosseini 7, Sepideh Hekmat 8, Zargham Hossein Ahmadi 9, Majid Dehghani 6, Alireza Saadat 10, Soura Mardpour 2, Seyedeh Esmat Hosseini 2,11, Maryam Esmaeilzadeh 12, Hakimeh Sadeghian 3, Gholamreza Bahoush 13, Ali Bassi 14, Ahmad Amin 15, Roghayeh Fazeli 2, Yaser Sharafi 10, Leila Arab 2, Mansour Movahhed 8, Saeid Davaran 3, Narges Ramezanzadeh 3, Azam Kouhkan 2, Ali Hezavehei 16, Mehrnaz Namiri 2, Fahimeh Kashfi 17, Ali Akhlaghi 17, Fattah Sotoodehnejadnematalahi 2, Ahmad Vosough Dizaji 18, Hamid Gourabi 19, Naeema Syedi 20, Abdolhosein Shahverdi 2, Hossein Baharvand 2, Nasser Aghdami 2,*
PMCID: PMC6005993  PMID: 29845801

This article published in Cell J (Yakhteh), Vol 20, No 2, Jul-Sep 2018, on pages 267-277, four affiliations (1, 4, 5, and 10) were changed based on authors request.

http://celljournal.org/journal/article/abstract/5197


Articles from Cell Journal (Yakhteh) are provided here courtesy of Royan Institute

RESOURCES